Arteriosclerosis, Vol 8, 207-211, Copyright © 1988 by American Heart Association

ARTICLES

High density lipoprotein cholesterol, total cholesterol screening, and myocardial infarction. The Framingham Study

RD Abbott, PW Wilson, WB Kannel and WP Castelli
Statistical Resource Section, National Heart, Lung, and Blood Institute, Bethesda, Maryland.

The relation between high density lipoprotein cholesterol (HDL-C) and the development of myocardial infarction was examined in 2425 subjects, aged 50 to 79 years, who were enrolled in the Framingham Study from 1969 to 1971. After 12 years of follow-up, men in the bottom three quartiles of HDL-C (less than or equal to 52 mg/dl) experienced a 60% to 70% excess of myocardial infarction as compared to men whose HDL-C levels were higher (p less than 0.05). The effect of HDL-C was especially strong in women. In separate comparisons to the 4th quartile of HDL-C (greater than or equal to 67 mg/dl), the risk of myocardial infarction increased from a fourfold excess in the adjacent 3rd quartile (56 to 66 mg/dl, p less than 0.01) to a nearly sixfold excess in the 1st quartile (less than or equal to 46 mg/dl, p less than 0.001). These results persisted after adjusting for age and other risk factors. In addition, a significant effect of HDL-C remained in subjects who had the lowest concentrations of total cholesterol (less than or equal to 192 mg/dl in men and 211 mg/dl in women) in which 29% had levels of HDL-C (less than or equal to 36 mg/dl in men and 46 mg/dl in women) that were associated with a marked elevation in the incidence of myocardial infarction. We conclude that screening for total cholesterol alone in men and women aged 50 and older may not adequately identify the coronary candidate.(ABSTRACT TRUNCATED AT 250 WORDS)

This article has been cited by other articles:

				S. J. Nicholls, E. M. Tuzcu, T. Crowe, I. Sipahi, P. Schoenhagen, S. Kapadia, S. L. Hazen, C.-C. Wun, M. Norton, F. Ntanios, et al. Relationship Between Cardiovascular Risk Factors and Atherosclerotic Disease Burden Measured by Intravascular Ultrasound J. Am. Coll. Cardiol., May 16, 2006; 47(10): 1967 - 1975. [Abstract] [Full Text] [PDF]

				P Collins Risk factors for cardiovascular disease and hormone therapy in women Heart, May 1, 2006; 92(suppl_3): iii24 - iii28. [Full Text] [PDF]

				K. Ullman HDL Becoming Important Piece of CHD Puzzle DOC News, February 1, 2006; 3(2): 9 - 9. [Full Text]

				M. B. Olson, D. S. Krantz, S. F. Kelsey, C. J. Pepine, G. Sopko, E. Handberg, W. J. Rogers, G. L. Gierach, C. K. McClure, C. N. B. Merz, et al. Hostility Scores Are Associated With Increased Risk of Cardiovascular Events in Women Undergoing Coronary Angiography: A Report from the NHLBI-Sponsored WISE Study Psychosom Med, July 1, 2005; 67(4): 546 - 552. [Abstract] [Full Text] [PDF]

				K. C. Maki, M. E. Van Elswyk, D. McCarthy, S. P. Hess, P. E. Veith, M. Bell, P. Subbaiah, and M. H. Davidson Lipid Responses to a Dietary Docosahexaenoic Acid Supplement in Men and Women with Below Average Levels of High Density Lipoprotein Cholesterol J. Am. Coll. Nutr., June 1, 2005; 24(3): 189 - 199. [Abstract] [Full Text] [PDF]

				M. Marchesi, E. A. Booth, T. Davis, C. L. Bisgaier, and B. R. Lucchesi Apolipoprotein A-IMilano and 1-Palmitoyl-2-oleoyl Phosphatidylcholine Complex (ETC-216) Protects the in Vivo Rabbit Heart from Regional Ischemia-Reperfusion Injury J. Pharmacol. Exp. Ther., December 1, 2004; 311(3): 1023 - 1031. [Abstract] [Full Text] [PDF]

				J. D. Curb, R. D. Abbott, B. L. Rodriguez, K. H. Masaki, R. Chen, J. S. Popper, H. Petrovitch, G. W. Ross, I. J. Schatz, G. C. Belleau, et al. High Density Lipoprotein Cholesterol and the Risk of Stroke in Elderly Men: The Honolulu Heart Program Am. J. Epidemiol., July 15, 2004; 160(2): 150 - 157. [Abstract] [Full Text] [PDF]

				C. Kluft Identifying patients at risk of coronary vascular disease: the potential role of inflammatory markers Eur. Heart J. Suppl., July 1, 2004; 6(suppl_C): C21 - C27. [Abstract] [Full Text] [PDF]

				J. D. Curb, R. D. Abbott, B. L. Rodriguez, K. Masaki, R. Chen, D. S. Sharp, and A. R. Tall A prospective study of HDL-C and cholesteryl ester transfer protein gene mutations and the risk of coronary heart disease in the elderly J. Lipid Res., May 1, 2004; 45(5): 948 - 953. [Abstract] [Full Text] [PDF]

				P Barter Is high-density lipoprotein the protector of the cardiovascular system? Eur. Heart J. Suppl., March 1, 2004; 6(suppl_A): A19 - A22. [Abstract] [Full Text] [PDF]

				S. Ho Hong, J. Rhyne, and M. Miller Novel Polypyrimidine Variation (IVS46: del T -39...-46) in ABCA1 Causes Exon Skipping and Contributes to HDL Cholesterol Deficiency in a Family With Premature Coronary Disease Circ. Res., November 14, 2003; 93(10): 1006 - 1012. [Abstract] [Full Text] [PDF]

				C.M. Ballantyne Raising high-density lipoprotein cholesterol: where are we now? Eur. Heart J. Suppl., June 1, 2003; 5(suppl_D): D17 - D25. [Abstract] [PDF]

				P. K. Shah, S. Kaul, J. Nilsson, and B. Cercek Exploiting the Vascular Protective Effects of High-Density Lipoprotein and Its Apolipoproteins: An Idea Whose Time for Testing Is Coming, Part I Circulation, November 6, 2001; 104(19): 2376 - 2383. [Full Text] [PDF]

				M. Perusse, A. Pascot, J.-P. Despres, C. Couillard, and B. Lamarche A new method for HDL particle sizing by polyacrylamide gradient gel electrophoresis using whole plasma J. Lipid Res., August 1, 2001; 42(8): 1331 - 1334. [Abstract] [Full Text] [PDF]

				O. Wiklund Treating lipids in cardiovascular disease: new directions Eur. Heart J. Suppl., May 1, 2001; 3(suppl_B): B27 - B31. [Abstract] [PDF]

				M. B. Olson, S. F. Kelsey, V. Bittner, S. E. Reis, N. Reichek, E. M. Handberg, C. N. Bairey Merz, and for the Women's Ischemia Syndrome Evaluation (WISE Weight cycling and high-density lipoprotein cholesterol in women: evidence of an adverse effect: A report from the NHLBI-sponsored WISE study J. Am. Coll. Cardiol., November 1, 2000; 36(5): 1565 - 1571. [Abstract] [Full Text] [PDF]

				C.G. Isles and J.R. Paterson Identifying patients at risk for coronary heart disease: implications from trials of lipid-lowering drug therapy QJM, September 1, 2000; 93(9): 567 - 574. [Abstract] [Full Text] [PDF]

				G. T Gerhard, S. L Connor, R. C Wander, and W. E Connor Plasma lipid and lipoprotein responsiveness to dietary fat and cholesterol in premenopausal African American and white women Am. J. Clinical Nutrition, July 1, 2000; 72(1): 56 - 63. [Abstract] [Full Text] [PDF]

				S D. Coello, A C. De Leon, F B. Ojeda, L. P. Mendez, L D. Gonzalez, and A. Aguirre-Jaime High density lipoprotein cholesterol increases with living altitude Int. J. Epidemiol., February 1, 2000; 29(1): 65 - 70. [Abstract] [Full Text] [PDF]

				D. K. Spady, D. M. Kearney, and H. H. Hobbs Polyunsaturated fatty acids up-regulate hepatic scavenger receptor B1 (SR-BI) expression and HDL cholesteryl ester uptake in the hamster J. Lipid Res., August 1, 1999; 40(8): 1384 - 1394. [Abstract] [Full Text]

				K. Kusterer, T. Pohl, H.-P. Fortmeyer, W. Marz, H. Scharnagl, A. Oldenburg, S. Angermuller, I. Fleming, K. H. Usadel, and R. Busse Chronic selective hypertriglyceridemia impairs endothelium-dependent vasodilatation in rats Cardiovasc Res, June 1, 1999; 42(3): 783 - 793. [Abstract] [Full Text] [PDF]

				W. A. Boisvert, A. S. Black, and L. K. Curtiss ApoA1 Reduces Free Cholesterol Accumulation in Atherosclerotic Lesions of ApoE–Deficient Mice Transplanted With ApoE–Expressing Macrophages Arterioscler Thromb Vasc Biol, March 1, 1999; 19(3): 525 - 530. [Abstract] [Full Text] [PDF]

				D. K. Spady, L. A. Woollett, R. S. Meidell, and H. H. Hobbs Kinetic characteristics and regulation of HDL cholesteryl ester and apolipoprotein transport in the apoA-I-/- mouse J. Lipid Res., July 1, 1998; 39(7): 1483 - 1492. [Abstract] [Full Text]

				S. M. Grundy, G. J. Balady, M. H. Criqui, G. Fletcher, P. Greenland, L. F. Hiratzka, N. Houston-Miller, P. Kris-Etherton, H. M. Krumholz, J. LaRosa, et al. Primary Prevention of Coronary Heart Disease: Guidance From Framingham : A Statement for Healthcare Professionals From the AHA Task Force on Risk Reduction Circulation, May 19, 1998; 97(18): 1876 - 1887. [Full Text] [PDF]

				A. Kaplan, S. Kaplan, K. F. Marcoe, L. R. Sauvage, and W. P. Hammond Identification of Potential Predisposition to Clinical Atherosclerosis: A Clinical Concept Based on Integration of Significant Blood Parameters with Platelet Aggregation Scores Clinical and Applied Thrombosis/Hemostasis, July 1, 1997; 3(3): 174 - 182. [Abstract] [PDF]

				C. M. Burchfiel, A. Laws, R. Benfante, R. J. Goldberg, L.-J. Hwang, D. Chiu, B. L. Rodriguez, J. D. Curb, and D. S. Sharp Combined Effects of HDL Cholesterol, Triglyceride, and Total Cholesterol Concentrations on 18-Year Risk of Atherosclerotic Disease Circulation, September 15, 1995; 92(6): 1430 - 1436. [Abstract] [Full Text]

				C. Otto, W. O. Richter, P. M. Ridker, D. E. Vaughan, J. C.W. van de Loo, F. Haverkate, and S. G. Thompson Hemostatic Factors and the Risk of Myocardial Infarction N. Engl. J. Med., August 10, 1995; 333(6): 389 - 390. [Full Text]

				A. C. King, W. L. Haskell, D. R. Young, R. K. Oka, and M. L. Stefanick Long-term Effects of Varying Intensities and Formats of Physical Activity on Participation Rates, Fitness, and Lipoproteins in Men and Women Aged 50 to 65 Years Circulation, May 15, 1995; 91(10): 2596 - 2604. [Abstract] [Full Text]

				F. Tato, G. L. Vega, and S. M. Grundy Bimodal Distribution of Cholesteryl Ester Transfer Protein Activities in Normotriglyceridemic Men With Low HDL Cholesterol Concentrations Arterioscler Thromb Vasc Biol, April 1, 1995; 15(4): 446 - 451. [Abstract] [Full Text]

				T. Hofer and J. Weissfeld Designing a Simpler High Blood Cholesterol Case Detection Strategy: Are the Advantages of the NCEP Protocol Worth the Complexity? Med Decis Making, October 1, 1994; 14(4): 357 - 368. [Abstract] [PDF]

				J. C LaRosa, W. Applegate, J. R. Crouse III, D. B. Hunninghake, R. Grimm, R. Knopp, J. H. Eckfeldt, C. E. Davis, and D. J. Gordon Cholesterol Lowering in the Elderly: Results of the Cholesterol Reduction in Seniors Program (CRISP) Pilot Study Arch Intern Med, March 14, 1994; 154(5): 529 - 539. [Abstract] [PDF]

				M. H. Criqui, G. Heiss, R. Cohn, L. D. Cowan, C. M. Suchindran, S. Bangdiwala, S. Kritchevsky, D. R. Jacobs, H. K. O'Grady, and C.E. Davis Plasma Triglyceride Level and Mortality from Coronary Heart Disease N. Engl. J. Med., April 29, 1993; 328(17): 1220 - 1225. [Abstract] [Full Text]

				P. W. F. Wilson and W. B. Kannel Is Baldness Bad for the Heart? JAMA, February 24, 1993; 269(8): 1035 - 1036. [Abstract] [PDF]

				S. M. Grundy and G. L. Vega Two Different Views of the Relationship of Hypertriglyceridemia to Coronary Heart Disease: Implications for Treatment Arch Intern Med, January 1, 1992; 152(1): 28 - 34. [Abstract] [PDF]

				J. R. Roeback Jr., K. M. Hla, L. E. Chambless, and R. H. Fletcher Effects of Chromium Supplementation on Serum High-Density Lipoprotein Cholesterol Levels in Men Taking Beta-Blockers: A Randomized, Controlled Trial Ann Intern Med, December 15, 1991; 115(12): 917 - 924. [Abstract] [PDF]

				J. C. Krakauer and J. D. Fachnie Gender and Lipids in Coronary Artery Disease Arch Intern Med, September 1, 1991; 151(9): 1881 - 1881. [Abstract] [PDF]

				R. A. Reinhart, S. K. Broste, and M. R. Arndt Gender and Lipids in Coronary Artery Disease-Reply Arch Intern Med, September 1, 1991; 151(9): 1881 - 1882. [Abstract] [PDF]

				P. Zimetbaum, W. Frishman, and M. Aronson Lipids, Vascular Disease, and Dementia With Advancing Age: Epidemiologic Considerations Arch Intern Med, February 1, 1991; 151(2): 240 - 244. [Abstract] [PDF]

				R. A. Reinhart, K. Gani, M. R. Arndt, and S. K Broste Apolipoproteins A-I and B as Predictors of Angiographically Defined Coronary Artery Disease Arch Intern Med, August 1, 1990; 150(8): 1629 - 1633. [Abstract] [PDF]

				G. L. Vega and S. M. Grundy Comparison of Lovastatin and Gemfibrozil in Normolipidemic Patients With Hypoalphalipoproteinemia JAMA, December 8, 1989; 262(22): 3148 - 3153. [Abstract] [PDF]

				A. M. Garber, H. C. Sox Jr, and B. Littenberg Screening Asymptomatic Adults for Cardiac Risk Factors: The Serum Cholesterol Level Ann Intern Med, April 15, 1989; 110(8): 622 - 639. [Abstract] [PDF]

				S. M. Grundy, D. S. Goodman, B. M. Rifkind, and J. I. Cleeman The Place of HDL in Cholesterol Management: A Perspective From the National Cholesterol Education Program Arch Intern Med, March 1, 1989; 149(3): 505 - 510. [Abstract] [PDF]